Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder To assess the efficacy of acute treatment with 10 mg/day vortioxetine versus placebo on cognitive performance (focusing on the aspect concerning speed of processing, executive functioning,...

• Pays Estonia, Finland, Germany, Lithuania
• Organes Aucun
• Spécialités Aucune

Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis Primary Objective: - To assess the long term safety of Sarilumab (SAR153191/REGN88) in patients with ankylosing spondylitis (AS) Secondary Objective: - To assess ...

• Pays Australia, Austria, Belgium, Canada, Czech Republic, France, Hungary, Lithuania, Netherlands, Poland, Spain, United States
• Organes Aucun
• Spécialités Aucune

Investigation of Early Hormonotherapy Efficacy of Prostate Cancer The purpose of this study is to determine whether early hormonotherapy is effective in the treatment of high risk prostate cancer patients after radical prostatectomy.

• Pays Lithuania
• Organes Aucun
• Spécialités Aucune

An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease The purpose of this study is to determine the long term safety and clinical utility of IPX066 in subjects with Parkinson's Disease.

• Pays Canada, Estonia, Germany, Latvia, Lithuania, Poland, Romania, Spain, Ukraine, United States
• Organes Aucun
• Spécialités Aucune

Pediatric Epilepsy Trial in Subjects 1-24 Months This study is being conducted to evaluate the effectiveness and safety of LAMICTAL added to the current therapy of pediatric patients age 1-24 months old with partial seizures. The medicat...

• Pays Australia, Estonia, France, Hungary, Italy, Latvia, Lebanon, Lithuania, Netherlands, Portugal, Slovakia, Spain, Turkey, United States
• Organes Aucun
• Spécialités Aucune

Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes The purpose of this protocol is to determine if an investigational drug known as LY333531 is effective in treating nerve malfunction in diabetes.

• Pays Canada, Croatia, Finland, India, Lithuania, Netherlands, United Kingdom, United States
• Organes Aucun
• Spécialités Aucune

Efficacy and safety of the S 05985 combination compared with each individual component: randomised, double-blind, placebo-controlled study over eight weeks in hypertensive patients Not provided at time of registration and not expected to be available in the future

• Pays France, Hungary, Latvia, Lithuania, Russian Federation, Ukraine
• Organes Aucun
• Spécialités Aucune

A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS) To evaluate the safety and tolerability of atacicept and to explore if atacicept reduces central nervous system inflammation in subjects with relapsing multiple sclerosis (RMS) as assessed...

• Pays Australia, Austria, Belgium, Canada, Czech Republic, France, Germany, Lebanon, Lithuania, Netherlands, Russian Federation, Spain, Sweden, Switzerland, Ukraine, United Kingdom, United States
• Organes Aucun
• Spécialités Aucune

Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients Not Adequately Responding to Aliskiren Alone This study will assess the safety and efficacy of combination aliskiren/amlodipine in patients not adequately controlled with aliskiren alone

• Pays Estonia, France, Iceland, India, Italy, Korea, Republic of, Lithuania, Spain, Venezuela, Bolivarian Republic of
• Organes Aucun
• Spécialités Aucune

Pregabalin Open-Label Extension Trial in Patients With Partial Seizures The primary purpose of the protocol is to evaluate the long-term safety of pregabalin in patients with partial seizures.

• Pays Austria, Canada, France, Germany, Italy, Lithuania, Spain, United Kingdom
• Organes Aucun
• Spécialités Aucune